Fulcrum Research Group

What Fulcrum Research Group does

Fulcrum Research Group operates as the market research sub-brand within SAI MedPartners' multi-brand consulting portfolio, delivering tailored quantitative and qualitative healthcare market research for pharmaceutical and biotechnology clients. Within SAI MedPartners' integrated structure, Fulcrum sits alongside three sibling brands — SAI MED (Competitive Intelligence), IDEA PHARMA (Path-to-Market + Positioning), and PHARMA FORCE (Syndicated Benchmarking + Deployment Analyzer) — enabling cross-sell across the pharma strategy value chain. The firm reports having supported 31% of new molecular entities (NMEs) launched since 2021 and claims hundreds of clients globally, with therapeutic area specialization spanning Oncology, Rare Disease, Immunology, Infectious Diseases + Vaccines, CNS, CKM, and Specialty Therapeutics.

The underlying operating entity is SAI MedPartners LLC, founded in 2016 and headquartered in Reading, Pennsylvania (Fulcrum's branded location is Waltham, Massachusetts). The firm maintains a 7-city global footprint (Reading, Waltham, London, Bangalore, Beijing, Shanghai, Zurich), combining local-market expertise with senior-level consulting engagement. Proprietary technical assets include the Synthetic Users methodology, the Deployment Analyzer syndicated benchmarking tool (accessed via a dedicated customer portal), the Pharma Innovation Index, and the IDEA Collider Podcast. These sit atop a combined clinical-and-commercial analytical platform designed for life sciences strategy consulting.

The business model blends professional services revenue (senior-level consulting engagements across competitive intelligence, market research, forecasting, market access, and path-to-market positioning) with subscription/recurring revenue from syndicated benchmarking products (Deployment Analyzer, Pharma Innovation Index) accessed via authenticated customer log-in portals. Go-to-market is sales-led and enterprise-focused, with quote-based pricing for consulting and event-driven thought leadership (e.g., 2024 Colorado Privacy Summit, IDEA Collider Podcast) supporting top-of-funnel demand. Customer segments are vertically concentrated in pharmaceutical and biotech companies, with primary use cases including competitive landscape analysis, market sizing, product positioning, and go-to-market strategy.

Name

Fulcrum Research Group

Legal name

SAI MedPartners LLC

Website

https://fulcrumresearchgroup.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Fulcrum Research Group is the market research sub-brand of SAI MedPartners, providing tailored quantitative and qualitative healthcare market research to pharmaceutical and biotechnology clients globally across seven cities.

Ownership category

akta.pro rank

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Strategy Consulting Engagements: Senior-level consulting engagements across competitive intelligence, life cycle management, market research, forecasting, market access and pricing, and path-to-market positioning for pharma and biotech clients.
2. Syndicated Reports: Subscription-based syndicated benchmarking reports covering sales force deployment and pharmaceutical market intelligence, accessible via customer log-in portals.
3. Deployment Analyzer: Subscription access to deployment benchmarking data and expert intelligence for pharmaceutical sales force strategy.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Fulcrum Research Group provides tailored healthcare market research delivering custom quantitative and qualitative insights that answer key business questions for pharmaceutical and biotech clients. Operating as the market research sub-brand of SAI MedPartners, it draws on integrated clinical and commercial expertise, customized methods, and proprietary benchmarking tools. The offering is part of SAI's four-practice platform spanning Competitive Intelligence, Market Research, Path-to-Market + Positioning, and Syndicated Benchmarking.

Product overview

SAI MedPartners operates a multi-brand portfolio providing life sciences strategy consulting services. Fulcrum Research Group (listed as FULCRUM RESEARCH) operates as a sub-brand under SAI MedPartners' market research division, offering tailored quantitative and qualitative healthcare market research. The portfolio includes related brands: SAI MED (Competitive Intelligence), IDEA PHARMA (Path-to-Market + Positioning), and PHARMA FORCE (Syndicated Benchmarking + Deployment Analyzer).

Differentiator

Problem solved

Functional benefit

Products and services

• Fulcrum Research Group - Tailored Healthcare Market Research

Quantifiable outcome

• SAI provided strategic support to 31% of NMEs launched since 2021

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Trinity Life Sciences: Trinity Life Sciences is a life sciences strategy consulting firm offering competitive intelligence, market research, forecasting, and syndicated benchmarking products to pharma and biotech clients — closely mirroring SAI MedPartners' integrated four-pillar value chain.
• ZS Associates: ZS is a global consulting and technology firm specializing in pharma sales, marketing, and analytics with proprietary data assets such as deployment analytics, directly comparable to SAI's Deployment Analyzer and syndicated benchmarking offerings.
• ClearView Healthcare Partners: ClearView is a boutique life sciences strategy consulting firm serving pharma and biotech on commercial strategy, CI, and new product planning — a direct competitor to SAI's CI, path-to-market, and market research practices.
• Simon-Kucher & Partners: Simon-Kucher is a global consulting firm with a strong life sciences practice focused on market access, pricing, and commercial strategy — directly overlapping with SAI's Market Access + Pricing and Path-to-Market offerings.
• Putnam Associates: Putnam is a life sciences-focused strategy consulting firm delivering commercial strategy, market assessment, and forecasting work to pharma and biotech — a directly comparable specialty competitor to SAI.
• Lumanity: Lumanity is a life sciences consulting firm providing commercial strategy, market access, and evidence generation services to pharma and biotech, with significant overlap to SAI's consulting and syndicated offerings.

Broad incumbents

• IQVIA: IQVIA is the largest life sciences services and data platform, offering consulting, real-world evidence, and syndicated market intelligence across all major therapy areas, competing with SAI in pharma strategy, market access, and benchmarking.
• Charles River Associates: CRA's Life Sciences practice provides strategy consulting, market assessment, and commercial diligence to pharma and biotech, competing with SAI across competitive intelligence and market research engagements.
• Informa (Pharma Intelligence / Citeline): Informa's Pharma Intelligence division operates large-scale syndicated pharma data, pipeline, and competitive intelligence products, competing with SAI's Deployment Analyzer and Pharma Innovation Index from a data-platform scale advantage.

Emerging players

• Defined Health (now part of Cello Health): Defined Health / Cello Health provides biotech-focused strategic consulting and medical communications, overlapping with SAI's biotech segment and therapeutic-area expertise practices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/FulcrumResearch

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fulcrum Research Group